| Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen D Maione, I Margarit, CD Rinaudo, V Masignani, M Mora, M Scarselli, ... Science 309 (5731), 148-150, 2005 | 668 | 2005 |
| Genome analysis reveals pili in Group B Streptococcus P Lauer, CD Rinaudo, M Soriani, I Margarit, D Maione, R Rosini, ... Science 309 (5731), 105-105, 2005 | 388 | 2005 |
| Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli DG Moriel, I Bertoldi, A Spagnuolo, S Marchi, R Rosini, B Nesta, ... Proceedings of the National Academy of Sciences 107 (20), 9072-9077, 2010 | 312 | 2010 |
| Identification of novel genomic islands coding for antigenic pilus‐like structures in Streptococcus agalactiae R Rosini, CD Rinaudo, M Soriani, P Lauer, M Mora, D Maione, A Taddei, ... Molecular microbiology 61 (1), 126-141, 2006 | 274 | 2006 |
| Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm I Margarit, CD Rinaudo, CL Galeotti, D Maione, C Ghezzo, E Buttazzoni, ... The Journal of infectious diseases 199 (1), 108-115, 2009 | 266 | 2009 |
| Biofilm formation by Streptococcus agalactiae: influence of environmental conditions and implicated virulence factors R Rosini, I Margarit Frontiers in cellular and infection microbiology 5, 6, 2015 | 145 | 2015 |
| Specific Involvement of Pilus Type 2a in Biofilm Formation in Group B Streptococcus CD Rinaudo, R Rosini, CL Galeotti, F Berti, F Necchi, V Reguzzi, ... PloS one 5 (2), e9216, 2010 | 134 | 2010 |
| Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1 F Doro, S Liberatori, MJ Rodríguez-Ortega, CD Rinaudo, R Rosini, ... Molecular & cellular proteomics 8 (7), 1728-1737, 2009 | 122 | 2009 |
| Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development M Rojas-Lopez, R Monterio, M Pizza, M Desvaux, R Rosini Frontiers in microbiology 9, 440, 2018 | 117 | 2018 |
| FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections B Nesta, G Spraggon, C Alteri, D Gomes Moriel, R Rosini, D Veggi, ... MBio 3 (2), 10.1128/mbio. 00010-12, 2012 | 117 | 2012 |
| Vaccines against antimicrobial resistance R Rosini, S Nicchi, M Pizza, R Rappuoli Frontiers in immunology 11, 520949, 2020 | 115 | 2020 |
| Sortase A Utilizes an Ancillary Protein Anchor for Efficient Cell Wall Anchoring of Pili in Streptococcus agalactiae AH Nobbs, R Rosini, CD Rinaudo, D Maione, G Grandi, JL Telford Infection and immunity 76 (8), 3550-3560, 2008 | 114 | 2008 |
| Use of Lactococcus lactis Expressing Pili from Group B Streptococcus as a Broad-Coverage Vaccine against Streptococcal Disease S Buccato, D Maione, CD Rinaudo, G Volpini, AR Taddei, R Rosini, ... The Journal of infectious diseases 194 (3), 331-340, 2006 | 107 | 2006 |
| Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes AR Flores, J Galloway-Peña, P Sahasrabhojane, M Saldaña, H Yao, X Su, ... Proceedings of the National Academy of Sciences 112 (20), 6431-6436, 2015 | 96 | 2015 |
| Pilus Backbone Contributes to Group B Streptococcus Paracellular Translocation through Epithelial Cells A Pezzicoli, I Santi, P Lauer, R Rosini, D Rinaudo, G Grandi, JL Telford, ... The Journal of infectious diseases 198 (6), 890-898, 2008 | 93 | 2008 |
| The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular … M Fabbrini, F Rigat, CD Rinaudo, I Passalaqua, S Khacheh, R Creti, ... Clinical Infectious Diseases 63 (6), 746-753, 2016 | 74 | 2016 |
| Structure of the type IX group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII F Berti, E Campisi, C Toniolo, L Morelli, S Crotti, R Rosini, MR Romano, ... Journal of Biological Chemistry 289 (34), 23437-23448, 2014 | 71 | 2014 |
| SslE Elicits Functional Antibodies That Impair In Vitro Mucinase Activity and In Vivo Colonization by Both Intestinal and Extraintestinal Escherichia coli Strains B Nesta, M Valeri, A Spagnuolo, R Rosini, M Mora, P Donato, CJ Alteri, ... PLoS pathogens 10 (5), e1004124, 2014 | 64 | 2014 |
| Genomic analysis reveals multi-drug resistance clusters in group B Streptococcus CC17 hypervirulent isolates causing neonatal invasive disease in southern mainland China E Campisi, R Rosini, W Ji, S Guidotti, M Rojas-Lopez, CD Rinaudo Frontiers in microbiology 7, 213628, 2016 | 52 | 2016 |
| Escherichia coli: great diversity around a common core DG Moriel, R Rosini, KL Seib, L Serino, M Pizza, R Rappuoli MBio 3 (3), 10.1128/mbio. 00118-12, 2012 | 49 | 2012 |
Daniela RinaudoSenior scientist at gskBestätigte E-Mail-Adresse bei novartis.com
